Opportunity

The Food and Drug Administration (FDA) Office of Acquisition and Grant Services issued solicitation FDA-RFP-1228764 to procure access to Over-the-Counter (OTC) drug utilization data and services. This requirement is classified under NAICS 541519 for Other Computer Related Services and PSC DA10 for IT and Telecom - Business Application/Application Development Software as a Service. The primary objective is to provide the agency with specialized data services to monitor and analyze the utilization of non-prescription medications.

The performance of these services is located in Silver Spring, Maryland. This combined synopsis/solicitation includes a response deadline of June 8, 2020, following its initial publication on May 7, 2020. Amendment 2, issued on May 28, 2020, revised the evaluation criteria specifically related to Factor 3, with changes highlighted in the updated solicitation documentation. Benjamin Golway serves as the point of contact for this procurement.

The solicitation package includes five attachments: the original RFP in both PDF and MS Word formats, a dedicated document for FDA responses to vendor questions, and two formal amendments. These documents establish the technical scope and evaluation framework for the data services required by the FDA. The procurement is managed as a direct federal acquisition with no specified set-aside designation in the provided metadata.